EverlyWell

Everlywell is an Austin, Texas-based at-home lab-testing and diagnostics company that lets consumers order test kits online, collect their own samples (blood, saliva, or swab) at home, and receive results reviewed by independent physicians through a mobile app and web dashboard. Test panels span daily health (thyroid, cholesterol, inflammation), digestive health (food sensitivity), sexual health (STI screening), hormone health, and broader biomarker panels processed through CLIA-certified labs.

The company was founded in 2015 by Julia Cheek, a former vice president of corporate strategy at MoneyGram, who remains founder and chief executive officer. Everlywell operates under the corporate legal entity Everly Health, Inc. (headquartered at 5209 Burnet Road, Suite 300, Austin, Texas 78756), which uses the Everlywell brand as its primary consumer-facing test platform alongside an Everly Health Solutions enterprise/partner business line.

Everlywell gained prominence during the COVID-19 pandemic after receiving FDA emergency use authorization in May 2020 for an at-home COVID-19 sample-collection kit, and it has separately built a public consumer profile through a November 2017 appearance on Shark Tank, which by 2023 press accounts described it as the second-highest-revenue company in the show's history.

In March 2021, Everlywell acquired PWNHealth and Home Access Health Corporation, forming a new parent holding company, Everly Health, with Julia Cheek becoming CEO of the combined entity; PWNHealth was rebranded Everly Health Solutions and operates as a distinct enterprise-facing subsidiary. Beyond that combination, no sourced reporting reviewed for this profile indicates Everly Health has been acquired by, or merged into, an outside company, has gone public, or has filed for bankruptcy; the company continued issuing consumer-facing press coverage (e.g., a February 2026 feature on its expanded biomarker panel) as an independently operated, privately held business.